Powered by

ResApp (ASX:RAP) receives TGA approval for ResAppDx-EU version 2

Feb 20, 2020 - ICT Monitor Worldwide

ResApp (RAP) has received Australian Therapeutic Good Administration (TGA) approval for its ResAppDx-EU version 2 smartphone app.

The TGA approval is an extension of the existing approval for ResAppDx-EU, adding the ability to test adults for lower respiratory tract disease, pneumonia, asthma and chronic obstructive pulmonary disease.

Most people will develop an acute respiratory tract infection every year and thus are the most commonly seen in primary care.

Currently, diagnosi...